Bromodomain protein BRD4 inhibition as a novel therapeutic approach in sunitinib-resistant renal cell carcinoma

Authors :: Masayuki Nakagawa
Hirofumi Yoshino
Satoru Sugita
Takashi Sakaguchi
Hideki Enokida
Youichi Osako
Kazutaka Miyamoto
Masaya Yonemori
Source :: European Urology Supplements. 17:e60
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
BRD4
business.industry
Sunitinib
Urology
medicine.disease
Bromodomain
03 medical and health sciences
Therapeutic approach
030104 developmental biology
Renal cell carcinoma
Cancer research
Medicine
business
medicine.drug

Tools